INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol MEDIORG
MSEI Symbol NOTLISTED
ISIN INE0PE401018
Name of Company MEDICAMEN ORGANICS LIMITED
Type of company SME
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 29-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 24-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 29-May-2025   15:00:00
End date and time of board meeting 29-May-2025   18:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion


Financial Results — Other than Bank
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 215772000 381877000
Other income 521000 950000
Total Income 216293000 382827000
2 Expenses
(a) Cost of materials consumed 124888000 222454000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -9519000 -8079000
(d) Employee benefit expense 19183000 36646000
(e) Finance costs 2919000 5136000
(f) Depreciation and amortisation expense 3728000 7368000
(g) Other Expenses
1 Direct Expenses 17943000 33261000
2 Other Expenses 24735000 31738000
Total other expenses 42678000 64999000
Total expenses 183877000 328524000
3 Profit before exceptional and extraordinary items and tax 32416000 54303000
4 Exceptional items 0 0
5 Profit before extraordinary items and tax 32416000 54303000
6 Extraordinary items 0 0
7 Profit before tax 32416000 54303000
8 Tax Expense
Current tax 7943000 14087000
Deferred tax -890000 -255000
Total tax expenses 7053000 13832000
9 Net Profit Loss for the period from continuing operations 25363000 40471000
10 Profit (loss) from discontinuing operations before tax 0 0
11 Tax expense of discontinuing operations 0 0
12 Net profit (loss) from discontinuing operation after tax 0 0
13 Profit (loss) for period before minority interest 25363000 40471000
14 Share of profit (loss) of associates 0 0
15 Profit (loss) of minority interest 0 0
16 Net profit (Loss) for the period 25363000 40471000
17 Details of equity share capital
Paid-up equity share capital 117000000 117000000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 176792000
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 2.19 3.67
Diluted earnings (loss) per share from continuing and discontinued operations 2.18 3.66
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio
23 Disclosure of notes on financial results


Remarks
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 54303000
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 0
Adjustments for depreciation and amortisation expense 5973000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss) 5973000
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories -13467000
Adjustments for decrease (increase) in trade receivables -91521000
Adjustments for decrease (increase) in other current assets 0
Adjustments for increase (decrease) in trade payables 46234000
Adjustments for increase (decrease) in other current liabilities 7050000
Adjustments for provisions 0
Total adjustments for working capital -51704000
Total adjustments for reconcile profit (loss) -45731000
Net cash flows from (used in) operations 8572000
Dividends received 0
Interest paid 0
Interest received -948000
Income taxes paid (refund) -944000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities before extraordinary items 8568000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) operating activities 8568000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 0
Purchase of property plant and equipment 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 948000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items 948000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) investing activities 948000
Cash flows from used in financing activities
Proceeds from issuing shares 31000000
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings -2995000
Repayments of borrowings -39000
Dividends paid 0
Interest paid -5136000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities before extraordinary items 33180000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) financing activities 33180000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 42696000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 42696000
Cash and cash equivalents cash flow statement at beginning of period 0
Cash and cash equivalents cash flow statement at end of period 42696000


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Equity and liabilities
1 Shareholders' funds
Share capital 117000000
Reserves and surplus 176792000
Money received against share warrants 7500000
Total shareholders' funds 301292000
2 Share application money pending allotment 0
3 Deferred government grants
4 Minority interest 3514000
5 Non-current liabilities
Long-term borrowings 1575000
Deferred tax liabilities (net) 11599000
Foreign currency monetary item translation difference liability account
Other long-term liabilities
Long-term provisions 2534000
Total non-current liabilities 15708000
6 Current liabilities
Short-term borrowings 121956000
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 10876000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 106156000
Total Trade payable 117032000
Other current liabilities 17643000
Short-term provisions 14929000
Total current liabilities 271560000
Total equity and liabilities 592074000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 101154000
Producing properties
Intangible assets 143000
Preproducing properties
Property, Plant and Equipment capital work-in-progress 22159000
Intangible assets under development or work-in-progress
Total Property, Plant and Equipment and Intangible assets 123456000
ii Non-current investments 0
v Deferred tax assets (net)
vi Foreign currency monetary item translation difference asset account
vii Long-term loans and advances 0
viii Other non-current assets 14296000
Total non-current assets 137752000
Current assets
Current investments 0
Inventories 74894000
Trade receivables 258522000
Cash and cash equivalents 41303000
Bank balance other than cash and cash equivalents 0
Short-term loans and advances 79603000
Other current assets
Total current assets 454322000
Total assets 592074000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 N C Raj & Associates Yes 28-Feb-2026